Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SRTM vs TVGN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TVGN Wins Head-to-Head Institutional Verdict (2–0 across 6 Pillars · 8–0 Matrix Metrics)

TVGN Overall Winner 6-Pillar Tally: SRTM 0 – 2 TVGN (4 Tie) Matrix Metrics: SRTM 0 – 8 TVGN

As of Nov 20, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over SRTM (SRTM) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). SRTM carries a Unified Composite Score of 47.6/100 (HOLD) at $0.08 (N/M Forward P/E, N/A operating margin), whereas TVGN carries 51.6/100 (HOLD) at $5.90 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SRTM vs TVGN
SRTM US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol N/A
Unified Composite Score
47.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
TVGN NASDAQ Head-to-Head Winner
Tevogen Bio Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$5.90
-6.35% 1D
Market Cap $432.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.32β · 69% Vol
Unified Composite Score
51.6 / 100 HOLD
Tech 42.0 Fund 51.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.4 · SMA20: $5.93 · SMA50: $6.60

6-Pillar Scorecard Institutional Category Breakdown (SRTM 0 – 2 TVGN)

Columns: Metric · SRTM · TVGN
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale TVGN
Revenue Growth (YoY) N/A +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A N/A
Market Cap N/A $432.7M
3. Profitability & Quality TVGN
Gross Margin N/A N/A
Operating Margin N/A 0.0%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A 0.0%
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SRTM (0) vs TVGN (8)
Institutional Metric SRTM TVGN Criterion Row Edge
Market Capitalization
Scale
N/A $432.7M Larger Scale TVGN
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +0.0% Higher Growth TVGN
Operating Margin (TTM)
Profitability
N/A 0.0% Higher Margin TVGN
Net Profit Margin
Profitability
N/A 0.0% Higher Margin TVGN
Return on Equity (ROE)
Capital Efficiency
N/A 0.0% Higher ROE TVGN
52-Week Range Position
Momentum
2% ($0–$1) 48% ($0–$12) Stronger Trend TVGN
Beta / 30D Volatility
Risk Regime
N/A 1.32β · 69% Vol Lower Realized Risk TVGN
Unified Institutional Score
Composite Signal
47.6 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite TVGN
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TVGN +67.04 pp
SRTM: -80.4% · TVGN: -13.36%
3M Horizon TVGN +73.98 pp
SRTM: -86.83% · TVGN: -12.85%
6M Horizon TVGN +73.98 pp
SRTM: -86.83% · TVGN: -12.85%
1Y Horizon TVGN +73.98 pp
SRTM: -86.83% · TVGN: -12.85%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs TVGN. Trailing 12-month operating profitability (SRTM N/A vs TVGN 0.0%) and valuation multiples (SRTM N/M vs TVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SRTM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
TVGN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SRTM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SRTM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TVGN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TVGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SRTM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
TVGN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $432.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SRTM vs TVGN Key Questions & Quantitative Answers

As of Nov 20, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over SRTM (SRTM) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). SRTM carries a Unified Composite Score of 47.6/100 (HOLD) at $0.08 (N/M Forward P/E, N/A operating margin), whereas TVGN carries 51.6/100 (HOLD) at $5.90 (N/M Forward P/E, 0.0% operating margin). Technically, SRTM sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and TVGN sits in a Neutral phase (RSI 46.4, UNCLASSIFIED options structure).

TVGN leads the Growth & Scale pillar: SRTM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TVGN at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, SRTM generates N/A in USD-normalized revenue versus N/A for TVGN. In operating R&D and SG&A reinvestment, SRTM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TVGN.

SRTM and TVGN trade at balanced relative valuation multiples. SRTM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TVGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SRTM (N/A ROE) versus TVGN (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SRTM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, TVGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.32β · 69% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.